RAJAFOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31

TFA Therapeutics, Inc.

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on May 15, 2026

$9.18+0.00 (0.00%)

Close on Oct 16, 2026

Community

Notes and questions about TFA Therapeutics from other investors

Discussion opens with sign-in. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.

Parsed from the XBRL in TFA Therapeutics's annual and quarterly filings with the SEC
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is RAJAF.

Revenue growth-0.6% · median -21.7%

Gross margin61.1% · median 31.7%

Operating margin-11.3% · median -110.9%

Net margin-12.4% · median -150.4%

Advertisement
300 × 250